1994
DOI: 10.1016/0091-6749(94)90115-5
|View full text |Cite
|
Sign up to set email alerts
|

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(15 citation statements)
references
References 13 publications
0
15
0
Order By: Relevance
“…When looking at results from other park studies with similar study periods, the filters' efficacy appears to compare positively with the efficacy found for antihistamines, 20,22 intranasal steroid sprays, 21,23 mast cell inhibitors, 24 and combination therapies. 25,26 In relation to placebo, these studies found first-day efficacies ranging from favoring placebo to roughly 50% improvements in symptoms.…”
Section: Discussionmentioning
confidence: 53%
See 1 more Smart Citation
“…When looking at results from other park studies with similar study periods, the filters' efficacy appears to compare positively with the efficacy found for antihistamines, 20,22 intranasal steroid sprays, 21,23 mast cell inhibitors, 24 and combination therapies. 25,26 In relation to placebo, these studies found first-day efficacies ranging from favoring placebo to roughly 50% improvements in symptoms.…”
Section: Discussionmentioning
confidence: 53%
“…This could prove important for patients because drowsiness is a well-known side effect to many antihistamines. 20,22,25,26 The nasal filter's positive effect on drowsiness and global discomfort increased when looking solely at the groups with baseline TNSSs of 0 or 1 (Table IV). These findings further underline the added benefit of initiating use of the filters before symptom onset.…”
Section: Discussionmentioning
confidence: 87%
“…Although azelastine nasal spray controlled symptoms when administered as needed, such treatment did not reduce allergic inflammation. Taste disturbances and twice-daily dosing associated with azelastine nasal spray might affect compliance; however, rates of treatment discontinuation ascribed to taste dis turbances or noncompliance were similar with azelastine and placebo in well-controlled clinical studies [52][53][54][55][56] .…”
Section: Phase IV Studies In Seasonal Allergic Rhinitismentioning
confidence: 99%
“…Two 2-day outdoor studies were conducted in city parks during the fall allergy season of 1989 to determine dose-ranging and the onset and duration of action of azelastine nasal spray 52,53 . As with the long-term studies, the TSC and MSC severity scores were used to evaluate the dosage groups.…”
Section: Dose-ranging and Onset-of-action Studiesmentioning
confidence: 99%
“…34,35 Both studies demonstrated that azelastine improved rhinitis symptoms within two hours after administration and lasted up to 24 hours suggesting that it could be administered once or twice a day.…”
Section: 31mentioning
confidence: 99%